Form 8-K - Current report:
SEC Accession No. 0001493152-26-007965
Filing Date
2026-02-25
Accepted
2026-02-25 09:00:23
Documents
15
Period of Report
2026-02-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 45528
2 EX-99.1 ex99-1.htm EX-99.1 17362
3 GRAPHIC ex99-1_001.jpg GRAPHIC 12096
  Complete submission text file 0001493152-26-007965.txt   296057

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE biaf-20260225.xsd EX-101.SCH 3768
5 XBRL DEFINITION FILE biaf-20260225_def.xml EX-101.DEF 26601
6 XBRL LABEL FILE biaf-20260225_lab.xml EX-101.LAB 36623
7 XBRL PRESENTATION FILE biaf-20260225_pre.xml EX-101.PRE 25225
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5334
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 26674518
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)